Shrewsbury, MA, United States of America

Andrew D Cherniack

This inventor holds 3 USPTO granted patents. Top assignee: University of Massachusetts. Active years: 2010-2013.


% Patents Active = 33.3

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Shrewsbury, MA (US) (2010 - 2012)
  • Worcester, MA (US) (2013)

Company Filing History:


Years Active: 2010-2013

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Andrew D Cherniack

Introduction

Andrew D Cherniack is an accomplished inventor based in Shrewsbury, MA (US). He has made significant contributions to the field of glucose transport and metabolism. With a total of 3 patents, his work focuses on addressing disorders related to glucose transport, such as diabetes and obesity.

Latest Patents

Cherniack's latest patents include groundbreaking research on RIP140 regulation of glucose transport. His findings indicate that the inhibition of RIP140 increases glucose transport, which can be beneficial in treating disorders associated with aberrant glucose transport, including diabetes. Additionally, he has developed compounds that inhibit RIP140 expression or activity, which are useful for treating obesity, increasing metabolism, and enhancing brown fat.

Career Highlights

Cherniack is affiliated with the University of Massachusetts, where he continues to advance research in his field. His innovative approaches have garnered attention and recognition within the scientific community.

Collaborations

Some of his notable coworkers include Michael P Czech and Aimee Powelka, who have collaborated with him on various research projects.

Conclusion

Andrew D Cherniack's contributions to the field of glucose transport and metabolism highlight his role as a significant inventor. His patents and research have the potential to impact the treatment of diabetes and obesity, showcasing the importance of innovation in addressing health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…